Weekly pill could shield vulnerable kids from TB
NCT ID NCT05122767
Summary
This study is checking if a weekly tuberculosis (TB) prevention treatment is safe and works well for children and teens who are living with HIV. Researchers want to see how this weekly treatment interacts with the modern HIV medications the participants are taking. The goal is to find a safe, effective way to prevent TB in this vulnerable group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peri Natal HIV Research Unit - Klerksdorp Tshepong Hospital
Klerksdorp, North West, 2571, South Africa
-
The Aurum Institute: Pretoria Clinical Research Centre
Pretoria, Gauteng, 0087, South Africa
Conditions
Explore the condition pages connected to this study.